Therapeutic Asset Ratings
435 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
VEMURAFENIB
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(59)
VEMURAFENIB
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
P2
B
(59)
VEMURAFENIB
Refractory Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(59)
Panobinostat
Acute Myeloid Leukemia
OHSU Knight Cancer Institute
P4
B
(58)
Abemaciclib
Prostate Cancer
OHSU Knight Cancer Institute
P3
B
(58)
Capecitabine
Ovarian Cancer
OHSU Knight Cancer Institute
P3
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Ovarian Cancer
OHSU Knight Cancer Institute
P3
B
(58)
TAMOXIFEN
Ovarian Cancer
OHSU Knight Cancer Institute
P3
B
(58)
Vinorelbine
Ovarian Cancer
OHSU Knight Cancer Institute
P3
B
(58)
Abemaciclib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
Carboplatin
Chronic Myelomonocytic Leukemia
OHSU Knight Cancer Institute
P2
B
(58)
Carboplatin
Refractory Malignant Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
Casodex
Breast Carcinoma
OHSU Knight Cancer Institute
P2
B
(58)
Gdc-0449
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
Gdc-0449
Recurrent Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
B
(58)
Gdc-0449
Refractory Malignant Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
gsk1120212
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Advanced Malignant Solid Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Recurrent Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
B
(58)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Refractory Malignant Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
Inno-206
Pancreatic Adenocarcinoma
OHSU Knight Cancer Institute
P2
B
(58)
Letrozole
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P2
B
(58)
Niraparib
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(58)
Nivolumab
Breast Carcinoma
OHSU Knight Cancer Institute
P2
B
(58)
Palbociclib
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
B
(58)
Showing 151 to 175 of 435 assets
Previous
Page 7 of 18
Next